- Home
- GNFT vs INSI Comparison
GNFT vs INSI Comparison
Compare GNFT & INSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- INSI
- Stock Information
- Founded
- GNFT 1999
- INSI 1971
- Country
- GNFT France
- INSI United States
- Employees
- GNFT N/A
- INSI N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- INSI Investment Managers
- Sector
- GNFT Health Care
- INSI Finance
- Exchange
- GNFT Nasdaq
- INSI Nasdaq
- Market Cap
- GNFT 172.2M
- INSI 183.7M
- IPO Year
- GNFT 2019
- INSI N/A
- Fundamental
- Price
- GNFT $3.66
- INSI $16.97
- Analyst Decision
- GNFT Strong Buy
- INSI
- Analyst Count
- GNFT 1
- INSI 0
- Target Price
- GNFT $13.00
- INSI N/A
- AVG Volume (30 Days)
- GNFT 6.9K
- INSI 22.0K
- Earning Date
- GNFT 09-19-2024
- INSI 01-01-0001
- Dividend Yield
- GNFT N/A
- INSI 4.90%
- EPS Growth
- GNFT N/A
- INSI N/A
- EPS
- GNFT 0.47
- INSI N/A
- Revenue
- GNFT $86,225,222.00
- INSI N/A
- Revenue This Year
- GNFT $145.20
- INSI N/A
- Revenue Next Year
- GNFT N/A
- INSI N/A
- P/E Ratio
- GNFT $7.56
- INSI N/A
- Revenue Growth
- GNFT 175.45
- INSI N/A
- 52 Week Low
- GNFT $3.35
- INSI $14.28
- 52 Week High
- GNFT $6.42
- INSI $16.40
- Technical
- Relative Strength Index (RSI)
- GNFT 44.80
- INSI 44.26
- Support Level
- GNFT $3.35
- INSI $16.96
- Resistance Level
- GNFT $3.57
- INSI $17.25
- Average True Range (ATR)
- GNFT 0.11
- INSI 0.21
- MACD
- GNFT 0.02
- INSI 0.01
- Stochastic Oscillator
- GNFT 56.36
- INSI 45.21
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About INSI Insight Select Income Fund
Insight Select Income Fund is a diversified closed-end, management investment company. The fund's investment objective is to seek a high rate of return, primarily from interest income and trading activity, from a portfolio principally consisting of debt securities. It offers various solutions such as risk management, liquidity management, and return generation among others.